Literature DB >> 26318107

SASH1, a new potential link between smoking and atherosclerosis.

Henri Weidmann1, Zahia Touat-Hamici2, Herve Durand2, Christian Mueller3, Solenne Chardonnet4, Cedric Pionneau4, Frédéric Charlotte5, Klaus-Peter Janssen6, Ricardo Verdugo7, Francois Cambien2, Stefan Blankenberg3, Laurence Tiret2, Tanja Zeller3, Ewa Ninio8.   

Abstract

OBJECTIVE: We have previously reported that SASH1 expression is increased in circulating human monocytes from smokers and was positively correlated with the number of carotid atherosclerotic plaques. The aim of this study was to further validate the link between smoking, SASH1 and atherosclerosis within the vascular wall and to assess the impact of SASH1 expression on endothelial cell functions.
METHOD: Human carotids with atherosclerotic plaques were obtained from 58 patients (45 of them with known smoking status: smoker, non-smoker, ex-smokers), and were processed for gene expression analyses and immunostaining. To investigate its function, SASH1 was silenced in human aortic endothelial cells (HAECs) using two different siRNA and subcellular localization of SASH1 was determined by immunostaining and subcellular fractionation. Subsequently the transcriptomic analyses and functional experiments (wound healing, WST-1 proliferation or Matrigel assays) were performed to characterize SASH1 function.
RESULTS: SASH1 was expressed in human vascular cells (HAECs, smooth muscle cells) and in monocytes/macrophages. Its tissue expression was significantly higher in the atherosclerotic carotids of smokers compared to non-smokers (p < 0.01). In HAECs, SASH1 was expressed mostly in the cytoplasm and SASH1 knockdown resulted in an increased cell migration, proliferation and angiogenesis. Transcriptomic and pathway analyses showed that SASH1 silencing results in a decreased CYP1A1 expression possibly through the inhibition of TP53 activity.
CONCLUSION: We showed that SASH1 expression is increased in atherosclerotic carotids in smokers and its silencing affects endothelial angiogenic functions; therefore we provide a potential link between smoking and atherosclerosis through SASH1 expression.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; CCND1; CCND3; SASH1; Smoking; TP53

Mesh:

Substances:

Year:  2015        PMID: 26318107     DOI: 10.1016/j.atherosclerosis.2015.08.013

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  10 in total

1.  The sbv IMPROVER Systems Toxicology Computational Challenge: Identification of Human and Species-Independent Blood Response Markers as Predictors of Smoking Exposure and Cessation Status.

Authors:  Vincenzo Belcastro; Carine Poussin; Yang Xiang; Maurizio Giordano; Kumar Parijat Tripathi; Akash Boda; Stéphanie Boué; Mario Guarracino; Florian Martin; Manuel C Peitsch; Julia Hoeng; Roberto Romero; Adi L Tarca; Zhongqu Duan; Hao Yang; Xiaofeng Gong; Peixuan Wang; Chenfang Zhang; Wenxin Yang; Omer Sinan Sarac; Ismail Bilgen; Ali Tugrul Balci; Rahul Kumar; Sandeep Kumar Dhanda
Journal:  Comput Toxicol       Date:  2017-07-14

2.  External validation of integrated genetic-epigenetic biomarkers for predicting incident coronary heart disease.

Authors:  Meeshanthini V Dogan; Stacey Knight; Timur K Dogan; Kirk U Knowlton; Robert Philibert
Journal:  Epigenomics       Date:  2021-06-21       Impact factor: 4.357

3.  Tobacco exposure-related alterations in DNA methylation and gene expression in human monocytes: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Lindsay M Reynolds; Kurt Lohman; Gary S Pittman; R Graham Barr; Gloria C Chi; Joel Kaufman; Ma Wan; Douglas A Bell; Michael J Blaha; Carlos J Rodriguez; Yongmei Liu
Journal:  Epigenetics       Date:  2018-01-16       Impact factor: 4.528

4.  Gene expression profiles associated with cigarette smoking and moist snuff consumption.

Authors:  Subhashini Arimilli; Behrouz Madahian; Peter Chen; Kristin Marano; G L Prasad
Journal:  BMC Genomics       Date:  2017-02-14       Impact factor: 3.969

5.  Identification of Smoking-Associated Differentially Methylated Regions Using Reduced Representation Bisulfite Sequencing and Cell type-Specific Enhancer Activation and Gene Expression.

Authors:  Ma Wan; Brian D Bennett; Gary S Pittman; Michelle R Campbell; Lindsay M Reynolds; Devin K Porter; Christopher L Crowl; Xuting Wang; Dan Su; Neal A Englert; Isabel J Thompson; Yongmei Liu; Douglas A Bell
Journal:  Environ Health Perspect       Date:  2018-04-27       Impact factor: 9.031

6.  HMGB1 contributes to SASH1 methylation to attenuate astrocyte adhesion.

Authors:  Ronghua Wu; Yingying Yan; Chao Ma; Han Chen; Zhangji Dong; Yongjun Wang; Yan Liu; Mei Liu; Liu Yang
Journal:  Cell Death Dis       Date:  2019-05-28       Impact factor: 8.469

7.  Transcriptomic analysis of monocytes from HIV-positive men on antiretroviral therapy reveals effects of tobacco smoking on interferon and stress response systems associated with depressive symptoms.

Authors:  David R Lorenz; Vikas Misra; Dana Gabuzda
Journal:  Hum Genomics       Date:  2019-11-28       Impact factor: 6.481

8.  Expression of SASH1 in Preeclampsia and Its Effects on Human Trophoblast.

Authors:  Shisan Liu; Sijia Jiang; Liping Huang; Yanhong Yu
Journal:  Biomed Res Int       Date:  2020-10-19       Impact factor: 3.411

9.  Disrupting LXRα phosphorylation promotes FoxM1 expression and modulates atherosclerosis by inducing macrophage proliferation.

Authors:  M C Gage; N Bécares; R Louie; K E Waddington; Y Zhang; T H Tittanegro; S Rodríguez-Lorenzo; A Jathanna; B Pourcet; O M Pello; J V De la Rosa; A Castrillo; I Pineda-Torra
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-27       Impact factor: 11.205

10.  The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.

Authors:  Fabian Christoph Franke; Johannes Müller; Miguel Abal; Eduardo Domínguez Medina; Ulrich Nitsche; Henri Weidmann; Solenne Chardonnet; Ewa Ninio; Klaus-Peter Janssen
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-09-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.